We conducted a randomized , double-blind , parallel , placebo-controlled trial in 88 men with T2D , aged 35-70 years with an HbA1c 8.5 % ( 69 mmol/mol ) , and a total testosterone level , measured by immunoassay , of 12.0 nmol/L ( 346 ng/dL ) .